NEJM endorsement of Real World studies

  This week, James Ware, Professor of Biostatistics at the Harvard School of Public Health in Boston and Mary Beth Hamel, writing in the New England Journal of Medicine (NEJM) further endorse the need for good quality pragmatic trials. They say that although randomised clinical trials provide essential, high quality evidence about the benefits and harms…